590 filings
Page 15 of 30
SC TO-I/A
py4hrb6kfwsy f57
1 May 20
Issuer tender offer statement (amended)
4:35pm
424B3
jhk178plzucs8c q5
1 May 20
Prospectus supplement
4:33pm
424B3
qp32nqeoboxnakc
1 May 20
Prospectus supplement
4:28pm
SC TO-I/A
chukm4 4lvs
22 Apr 20
Issuer tender offer statement (amended)
4:34pm
8-K
cxhw6
22 Apr 20
Entry into a Material Definitive Agreement
4:19pm
8-K
qll6g
21 Apr 20
Other Events
4:28pm
8-K
cnydkc x2qa
9 Apr 20
Other Events
5:16pm
8-K
e1t5d
6 Apr 20
Other Events
4:14pm
SC TO-I/A
fe04u
6 Apr 20
Issuer tender offer statement (amended)
4:07pm
SC TO-I/A
mvsz4rcw7 mgj
30 Mar 20
Issuer tender offer statement (amended)
4:51pm
8-K
j59gc68ggxylm690kapu
23 Mar 20
Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational Updates
6:48am
SC TO-I/A
voo90ty
20 Mar 20
Issuer tender offer statement (amended)
4:18pm
8-K
7cdkgw 1j7fpyb9qb7ss
19 Mar 20
Termination of a Material Definitive Agreement
5:16pm
8-K
ngpbmxtfwjp9 kft
12 Mar 20
Innovate Biopharmaceuticals Affirms Timeline for Closing of Merger with RDD Pharma Ltd. Closing Expected Around the End of the First Quarter of 2020
4:22pm
SC TO-I/A
t03 awq4o7
11 Mar 20
Issuer tender offer statement (amended)
4:16pm
CORRESP
w4ar neaj
11 Mar 20
Correspondence with SEC
12:00am
UPLOAD
ehfg5v3o4j31xxo7lc
9 Mar 20
Letter from SEC
12:00am
SC TO-I/A
6ox4tud
28 Feb 20
Issuer tender offer statement (amended)
5:23pm